Stephen M. Condon

3.7k citations

38 papers · 2.5k indexed · 2 hit papers · h-index 18

Co-authors: John Silke David L. Vaux Christopher A. Benetatos James E. Vince W. Wei‐Lynn Wong Srinivas K. Chunduru Mark A. McKinlay Nufail Khan
Topics: Cell death mechanisms and regulation (10 papers)Synthetic Organic Chemistry Methods (8 papers)Ubiquitin and proteasome pathways (6 papers)
Cited by: Immunology Cancer Research Molecular Biology
Journals: Cell Journal of the American Chemical Society Journal of Biological Chemistry
Partner nations: United States Australia Switzerland

In The Last Decade

Stephen M. Condon

36 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis

2007 879 citations James E. Vince, W. Wei‐Lynn Wong et al. Cell profile →
RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL

2015 510 citations Kate E. Lawlor, Nufail Khan et al. Nature Communications profile →

Peers

Countries citing papers authored by Stephen M. Condon

Since Specialization

Citations

This map shows the geographic impact of Stephen M. Condon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen M. Condon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen M. Condon more than expected).

Fields of papers citing papers by Stephen M. Condon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen M. Condon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen M. Condon. The network helps show where Stephen M. Condon may publish in the future.

Co-authorship network of co-authors of Stephen M. Condon

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen M. Condon. A scholar is included among the top collaborators of Stephen M. Condon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen M. Condon. Stephen M. Condon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The dose–response effects of hydrolyzed curcumin on recovery, inflammation, and oxidative stress following exercise‐induced muscle damage in males 2025 ·Physiological Reports ·(unknown),Stephen M. Condon,I. S. Grant,Nathan A. Lewis,Jessica Hill,Charles R. Pedlar,Luke Hughes	0
2	Combination of IAP antagonist and IFNγ activates novel caspase-10- and RIPK1-dependent cell death pathways 2017 ·Cell Death and Differentiation ·Maria C. Tanzer,Nufail Khan,James Rickard,Nima Etemadi,Najoua Lalaoui,Sukhdeep K. Spall,Joanne M. Hildebrand,David Segal,Maria Miasari,Diep Chau,W. Wei‐Lynn Wong,Mark A. McKinlay,Srinivas K. Chunduru,Christopher A. Benetatos,Stephen M. Condon,James E. Vince,Marco J. Herold,John Silke	38
3	Bivalent IAP antagonists inhibit TRAF2-bound cIAPs and limit TNF-mediated NF-κB signaling 2016 ·Cell Death and Disease ·Stephen M. Condon	3
4	Process Development of the Soft Histone Deacetylate Enzyme Inhibitor SHP-141: Acylation of Methyl Paraben and Suberyl Hydroxamic Acid Formation 2016 ·Organic Process Research & Development ·Yijun Deng,(unknown),(unknown),(unknown),Jaclyn White,(unknown),(unknown),Parveen Akhtar,Lei Zhu,(unknown),(unknown),Stephen M. Condon	2
5	RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKLbreakdown → 2015 ·Nature Communications ·Kate E. Lawlor,Nufail Khan,(unknown),Motti Gerlic,Ben A. Croker,Akshay A. D’Cruz,Cathrine Hall,Sukhdeep K. Spall,Holly Anderton,Seth L. Masters,Maryam Rashidi,Ian P. Wicks,Warren S. Alexander,Yasuhiro Mitsuuchi,Christopher A. Benetatos,Stephen M. Condon,W. Wei‐Lynn Wong,John Silke,David L. Vaux,James E. Vince	510
6	Abstract 2278: The SMAC-mimetic birinapant regulates autocrine TNF production by caspase-8:RIPK1 complex via p38MAPK pathway 2014 ·Cancer Research ·Gurpreet S. Kapoor,Christopher A. Benetatos,Yasuhiro Mitsuuchi,Eric M. Neiman,Guangyao Yu,Mark A. McKinlay,Jennifer M. Burns,John Silke,Stephen M. Condon,Srinivas K. Chunduru	1
7	Smac Mimetics Activate the E3 Ligase Activity of cIAP1 Protein by Promoting RING Domain Dimerization 2011 ·Journal of Biological Chemistry ·Rebecca Feltham,(unknown),Rhesa Budhidarmo,Peter D. Mace,Sarah Shirley,Stephen M. Condon,Srinivas K. Chunduru,Mark A. McKinlay,David L. Vaux,John Silke,Catherine L. Day	120
8	Abstract LB-406: Phase 1 study of the Smac mimetic TL32711 in adult subjects with advanced solid tumors and lymphoma to evaluate safety, pharmacokinetics, pharmacodynamics, and antitumor activity 2011 ·Cancer Research ·Ravi K. Amaravadi,Russell J. Schilder,Grace K. Dy,Wen Wang,Gerald J. Fetterly,David Weng,Martin A. Graham,Jennifer Burns,Srinivas K. Chunduru,Stephen M. Condon,Mark A. McKinlay,Alex A. Adjei	17
9	The discovery and structure–activity relationships of pyrano[3,4-b]indole-based inhibitors of hepatitis C virus NS5B polymerase 2011 ·Bioorganic & Medicinal Chemistry Letters ·Randy W. Jackson,Matthew G. LaPorte,Torsten Herbertz,(unknown),(unknown),Susan R. Rippin,Ravi M. Patel,Srinivas K. Chunduru,Christopher A. Benetatos,Dorothy C. Young,Christopher J. Burns,Stephen M. Condon	17
10	The discovery and structure–activity relationships of pyrano[3,4-b]indole based inhibitors of hepatitis C virus NS5B polymerase 2010 ·Bioorganic & Medicinal Chemistry Letters ·Matthew G. LaPorte,(unknown),(unknown),Charles W. Blackledge,Lara K. Leister,(unknown),(unknown),Dorothy C. Young,Srinivas K. Chunduru,Christopher A. Benetatos,Gerry Rhodes,Ariamala Gopalsamy,Torsten Herbertz,Christopher J. Burns,Stephen M. Condon	33
11	Sensitization of human bladder tumor cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis with a small molecule IAP antagonist 2010 ·APOPTOSIS ·Thomas S. Griffith,Tamara A. Kucaba,Michael A. O’Donnell,Jennifer M. Burns,Christopher A. Benetatos,Mark A. McKinlay,Stephen M. Condon,Srinivas K. Chunduru	25
12	TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1–TRAF2 complex to sensitize tumor cells to TNFα 2008 ·The Journal of Cell Biology ·James E. Vince,Diep Chau,Bernard A. Callus,W. Wei‐Lynn Wong,Christine J. Hawkins,Pascal Schneider,Mark A. McKinlay,Christopher A. Benetatos,Stephen M. Condon,Srinivas K. Chunduru,George C. Yeoh,Robert Brink,David L. Vaux,John Silke	209
13	IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosisbreakdown → 2007 ·Cell ·James E. Vince,W. Wei‐Lynn Wong,Nufail Khan,Rebecca Feltham,Diep Chau,Afsar U. Ahmed,Christopher A. Benetatos,Srinivas K. Chunduru,Stephen M. Condon,Mark A. McKinlay,Robert Brink,Martin Leverkus,Vinay Tergaonkar,Pascal Schneider,Bernard A. Callus,Frank Köentgen,David L. Vaux,John Silke	879
14	Benzimidazoles and isosteric compounds as potent and selective factor Xa inhibitors 2002 ·Bioorganic & Medicinal Chemistry Letters ·Wei He,Barbara Hanney,Michael R. Myers,Stephen M. Condon,Michael R. Becker,Alfred P. Spada,Christopher J. Burns,Karen Brown,Dennis Colussi,Valeria Chu	6
15	Analogues of Human Parathyroid Hormone (1–31)NH2: Further Evaluation of the Effect of Conformational Constraint on Biological Activity 2002 ·Bioorganic & Medicinal Chemistry ·Stephen M. Condon,(unknown),Christopher J. Burns,Mark A. Bobko,Isabelle Morize,Joanne Uhl,(unknown),Kathleen A. Burke,Richard Labaudinière	1
16	The Bioactive Conformation of Human Parathyroid Hormone. Structural Evidence for the Extended Helix Postulate 2000 ·Journal of the American Chemical Society ·Stephen M. Condon,Isabelle Morize,(unknown),Christopher J. Burns,Bruce E. Miller,Joanne Uhl,Kathleen A. Burke,(unknown),(unknown),Paul Krolikowski,N. Vasant Kumar,Richard Labaudinière	39
17	Nanomolar Inhibitors for Two Distinct Biological Target Families from a Single Synthetic Sequence: A Next Step in Combinatorial Library Design? 1998 ·Angewandte Chemie International Edition ·Christopher J. Burns,Robert D. Groneberg,Joseph M. Salvino,Gerard M. McGeehan,Stephen M. Condon,Robert W. Morris,(unknown),Rose Mathew,(unknown),Kent Neuenschwander,(unknown),Stevan W. Djurić,(unknown),Richard Labaudinière	14
18	A Unified Total Synthesis of the Immunomodulators (−)-Rapamycin and (−)-27-Demethoxyrapamycin: Assembly of the Common C(1−20) Perimeter and Final Elaboration 1997 ·Journal of the American Chemical Society ·Amos B. Smith,Stephen M. Condon,John A. McCauley,Johnnie L. Leazer,James W. Leahy,Robert E. Maleczka	65
19	A Unified Total Synthesis of the Immunomodulators (−)-Rapamycin and (−)-27-Demethoxyrapamycin: Construction of the C(21−42) Perimeters 1997 ·Journal of the American Chemical Society ·Amos B. Smith,Stephen M. Condon,John A. McCauley,Johnnie L. Leazer,James W. Leahy,Robert E. Maleczka	59
20	Synthetic applications of gilman reagents derived from 2-bromo-2-cycloalken-1-one Ethylene Ketals 1991 ·Tetrahedron Letters ·George Majetich,(unknown),Stephen M. Condon	17

About Stephen M. Condon

Stephen M. Condon is a scholar working on Organic Chemistry, Hepatology and Molecular Biology, having authored 38 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (10 papers), Synthetic Organic Chemistry Methods (8 papers) and Ubiquitin and proteasome pathways (6 papers). The work is most often cited by research in Immunology (818 citations), Cancer Research (506 citations) and Molecular Biology (1.8k citations). Stephen M. Condon has collaborated with scholars based in United States, Australia and Switzerland. Frequent co-authors include John Silke, David L. Vaux, Christopher A. Benetatos, James E. Vince, W. Wei‐Lynn Wong, Srinivas K. Chunduru, Mark A. McKinlay, Nufail Khan, Diep Chau and Pascal Schneider. Their work appears in journals such as Cell, Journal of the American Chemical Society and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact